Skip to content

MISSION-CJ for Justice-Involved Homeless Veterans

A Randomized Controlled Trial of MISSION-CJ for Justice-Involved Homeless Veterans With Co-Occurring Substance Use and Mental Health Disorders

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04523337
Acronym
MISSION-CJ
Enrollment
134
Registered
2020-08-21
Start date
2021-07-01
Completion date
2026-02-28
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Homelessness, Mental Health Disorder, Substance Use Disorder

Keywords

Veterans, Co-Occurring Disorder, Homeless Persons, crime, substance-related disorders, mental disorders

Brief summary

The purpose of this study is to determine whether Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking - Criminal Justice version (MISSION-CJ) is effective for reducing criminal recidivism and improving other health-related outcomes (substance use, mental health, housing, employment, community integration) among justice-involved, homeless Veterans with a co-occurring substance use and mental health disorder.

Detailed description

VHA Mental Health Residential Rehabilitation Treatment Programs (MH RRTPs) serve Veterans with an estimated 50% having criminal justice involvement annually. Justice-involved Veterans (JIVs) receive assistance with their addiction and behavioral health needs, but MH RRTP programs do not directly address their antisocial behaviors and cognitions. Furthermore, MH RRTP discharge is a vulnerable transition and no national transitional approach facilitates Veteran's engagement in prosocial community behaviors that sustain MH RRTP gains, ultimately reducing revolving door service use. Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice version (MISSION-CJ) is a new case manager and peer delivered team-based treatment for JIVs with a co-occurring substance use and mental health disorder (COD). While MISSION-CJ derives in part from an evidence-based treatment for homeless individuals (MISSION), it includes a new conceptual framework and numerous new and differentiating features for a CJ population including: (1) a treatment planning tool focused on criminogenic needs that monitors progress and tunes service delivery elements; (2) a prosocial treatment curriculum; and (3) tools/resources to address JIVs' legal issues. With MISSION-CJ, this study attempts to change the practice paradigm and transform care for JIVs by moving beyond the current model of linking Veterans to VA care and tracking behavioral health outcomes, to a hybrid treatment/linkage approach that addresses criminogenic needs, supports engagement in VA and non-VA care, and targets recidivism as an outcome-the gold standard for CJ research. Using a Hybrid Type 1 design, this project will test the effectiveness of MISSION-CJ in a three-site RCT (Bedford, Palo Alto, and Little Rock VAs) with JIVs with a COD, admitted to an MH RRTP, and previously arrested and charged and/or released from incarceration in the past 5-years.

Interventions

BEHAVIORALMaintaining Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice

Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice version (MISSION-CJ) programming targets co-occurring substance use and mental health disorders and other related health outcomes faced by justice-involved homeless Veterans through assertive outreach, psychoeducation, and linkages to community-based services. Patients will receive 2 hours of MISSION-CJ services per week during and after their stay in the mental health residential rehabilitation program (total of 6-months). Services are delivered using a Critical Time Intervention stepdown approach.

BEHAVIORALMaintaining Maintaining Independence and Sobriety through Systems Integration Outreach and Networking Peer Support

The MISSION Peer Support Curriculum is rolling entry, and includes 24, one-hour exercises focused on co-occurring substance use and mental health disorders, recovery, and community integration.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Research assistants conducting the 6- and 15-month outcome assessments are blinded to the condition assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* (a) are entering a Mental Health Residential Rehabilitation Treatment Program (MH RRTP) * (b) were arrested and charged and/or released from incarceration in the past 5 years * (c) have a co-occurring substance use and mental health disorder (COD)

Exclusion criteria

* The only exclusion criterion is being too cognitively impaired to understand the informed-consent process and other study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Criminal recidivismthrough study completion, on average 15-monthsNumber of arrests based on records from the California and Massachusetts Department of Corrections records; and arrest and incarceration records from the National Crime Information Center.
Criminal Recidivismthrough study completion, on average 15-monthsNumber of nights in jail or prison based on records from the California and Massachusetts Department of Corrections records; and arrest and incarceration records from the National Crime Information Center.

Secondary

MeasureTime frameDescription
Change in Substance Use (Illicit Drug Use Timeline Follow back - TLFB)Baseline, 6-months, 15-monthsQuantity of patients' self-reported illicit drug use in the past 90 days. Frequency and quantity will be combined to measure drug use severity.
Change in Trauma Symptoms (PTSD Checklist for DSM-5 - PCL-5)Baseline, 6-months, 15-monthsChanges in the severity of patients' PTSD symptoms. A total severity score is computed by summing all the items. Scores range from 0-80 with higher scores indicating higher severity.
Change in Depression (Patient Health Questionnaire-9 - PHQ-9)Baseline, 6-months, 15-monthsChanges in the degree of depression severity self-reported by patients. Total scores range from 0-27 with higher scores indicating more severe depression.
Change in Mental Health Symptoms (Behavior and Symptom Identification Scale-24 - BASIS-24)Baseline, 6-months, 15-monthsChanges in the severity of patients' self-reported psychiatric symptoms across 6 subscales (e.g. Depression and Functioning, Interpersonal Relationships, Self-Harm, Psychosis, Substance Abuse, and Emotional Lability) during the past week. Patients score items on a scale of 0-4, and each subscale and mean total score range from 0-4, with higher scores indicating higher levels of severity of symptoms.
Change in Recidivism risk (Level of Service Inventory-Revised)Baseline, 6-months, 15-monthsChanges in the severity of patients' self-reported legal problems. Self-reported arrests, charges, and months incarcerated since the baseline assessment. Total LSI-R scores will be used. Scores range from 0-54 with higher scores indicating greater risk.
Change in Medication Adherence Rating Scale (MARS)Baseline, 6-months, 15-monthsPatients' self-reported compliance with medication. Questions are dichotomous yes/no.
Change in Housing Status (Residential Timeline Follow back)Baseline, 6-months, 15-monthsQuantity of patients' self-reported days homeless in the past 90 days.
Change in Employment (Maudsley Addiction Profile)Baseline, 6-months, 15-monthsQuantity of days worked, days absent, and days unemployed in the past 30 days, as self-reported by patients since the baseline assessment.
Treatment Engagement (MISSION Treatment Services Tracking SheetUp to 12 monthsNumber of services for both VA and non-VA services received (pre- and post-MH RRTP). This includes all possible services offered within MISSION-CJ and EUC (MISSION Peer Support) as well as community linkages. Regarding linkages, the measure quantifies the number of referrals, referral type, and client engagement. Examine change in number of services received during 12 months, collected on a weekly basis.
Treatment Engagement (MISSION Treatment Services Tracking Sheet)Up to 12 monthsTypes of services for both VA and non-VA services received (pre- and post-MH RRTP). This includes all possible services offered within MISSION-CJ and Enhanced Usual Care (MISSION Peer Support) as well as community linkages. Examine change in types of services received during 12 months, collected on a weekly basis.
Change in Treatment Engagement (Alcoholics Anonymous Involvement Scale - AAI)Baseline, 6-months, 15-monthsChange in patients' self-reported involvement in 12-step groups for substance use. Items are dichotomous yes/no, with yes responses indicating more involvement in 12-step groups. Composite scores range from 0-9 with 9 indicating more involvement in 12-step groups. Patients are also asked to indicate which of the 12-steps they have worked.
Treatment Engagement (Healthcare Continuing Care Utilization)12-month period prior to, and ending 15 months after, study enrollmentData on SUD/MH continuing care utilization since the prior assessment will be defined as the number of sessions in each setting that the clients attend throughout the follow-up period. Both will be obtained from: (a) CDW, for VA care and (b) service tracking sheets for VA and non-VA health care utilization. For VA care, the electronic medical record data will be obtained from the CDW. CDW data includes both outpatient encounter records (including the type of outpatient care - e.g., from outreach programs, office-based clinical services) and information on inpatient and residential care services used.
Treatment Engagement (MH RRTP Completion)12-month period prior to, and ending 15 months after, study enrollmentHealthcare utilization includes both VA and non-VA healthcare services and we will construct several measures. MH RRTP completion will be defined as a regular discharge from the program and determined from the VA's Corporate Data Warehouse (CDW).
Change in Antisocial Attitudes (Measures of Criminal Attitudes and Associates - MCAA)Baseline, 6-months, 15-monthsChanges in patients' self-report of antisocial attitudes on 4 scales: violence, entitlement, antisocial intent, and associates. Responses to MCAA Part B are dichotomous agree/disagree.
Change in Community Integration Measure (CIM)Baseline, 6-months, 15-monthsPatient's self-report perspective of their integration into their home and community are scored on a 5-point scale. A single summary score (range 10-50) is computed by summing each item, with lower scores indicating
Change in Affiliations with Antisocial Peers (Measures of Criminal Attitudes and Associates: MCAA)Baseline, 6-months, 15-monthsChanges in patients' self-report of criminal associations. Part A of the MCAA is intended to quantify criminal associations. In Part A, respondents are asked to recall the four adults in the community with whom they spend the most free time. For each adult, they then indicate how much of their free time is spent in their associate's company. The respondent then answers four questions regarding the degree of criminal involvement of their associates: (a) Has this person ever committed a crime; (b) Does this person have a criminal record; (c) Has this person ever been to jail? and (d) Has this person tried to involve you in a crime? From this information, a measure of criminal associates can be calculated. The Number of Criminal Friends is calculated by totaling the number of friends for which the respondent answers yes to any of the questions of criminal involvement.
Change in Substance use (Alcohol Use Timeline Follow-back -TLFB)Baseline, 6-months, 15-monthsQuantity of patients' self-reported alcohol use in the past 90 days. Frequency and quantity will be combined to measure alcohol use severity.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid A. Smelson, PsyD

VA Bedford HealthCare System, Bedford, MA

PRINCIPAL_INVESTIGATORDaniel M. Blonigen, PhD MA

VA Palo Alto Health Care System, Palo Alto, CA

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026